.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Cerilliant
Cantor Fitzgerald
Federal Trade Commission
Deloitte
Accenture
Merck
Chubb
Teva
Fish and Richardson

Generated: June 26, 2017

DrugPatentWatch Database Preview

RESERPINE Drug Profile

« Back to Dashboard

What is the patent landscape for Reserpine, and when can generic versions of Reserpine launch?

Reserpine is a drug marketed by Watson Labs, Tablicaps, Pvt Form, Teva, Barr, Whiteworth Town Plsn, Mk Labs, Impax Labs, Rexall, Sandoz, Everylife, Elkins Sinn, Solvay, Purepac Pharm, Halsey, Bell Pharma, Cycle Pharms Ltd, Bundy, Pharmavite, Valeant Pharm Intl, Mylan, Hikma Intl Pharms, Ivax Sub Teva Pharms, Marshall Pharma, West Ward, Par Pharm, Ivax Pharms, Sun Pharm Inds, and Lederle. and is included in forty-one NDAs.

The generic ingredient in RESERPINE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Summary for Tradename: RESERPINE

Patents:0
Applicants:29
NDAs:41
Bulk Api Vendors: see list47
Clinical Trials: see list12
Patent Applications: see list3,449
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RESERPINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms
RESERPINE
reserpine
TABLET;ORAL080975-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Cycle Pharms Ltd
RESERPINE
reserpine
TABLET;ORAL009859-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Marshall Pharma
RESERPINE
reserpine
TABLET;ORAL080492-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds
RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL088570-001Apr 10, 1984DISCNNoNo► Subscribe► Subscribe
Pvt Form
RESERPINE
reserpine
TABLET;ORAL080582-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
US Army
Express Scripts
QuintilesIMS
Boehringer Ingelheim
Baxter
Merck
Mallinckrodt
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot